Neurology

Glunomab may inhibit the progression of motor disorders associated with multiple sclerosis.

Glunomab may inhibit the progression of motor disorders associated with multiple sclerosis.

The relevancy of randomized controlled trials of experimental drugs for multiple sclerosis in standard practice called into question.

A small proportion of patients with autoimmune syndrome have diabetes.

Add-on therapy to interferon beta-1a is a potentially groundbreaking oral antibiotic combination.

Multiple types of spinal cord stimulation could be used to treat chronic back and limb pain.

Researchers target causes of severe depression in MS patients.

Microorganisms in the gut play a role in inflammation among patients with multiple sclerosis.

Is the cost of specialty drugs worth the price in small patient populations?

Four genes found linked to epigenetic mechanisms that contribute to multiple sclerosis.

Resistance and endurance exercises may improve muscle growth and repair in multiple sclerosis patients.

Mice treated with rapamycin showed improved locomotor function and reduced sensitivity.

Evidence builds supporting the use of fecal transplants to treat infections in the gut microbiome.

Levels of good and bad gut bacteria influences autoimmune disease.

Obstructive sleep apnea in MS patients can lead to deeper problems.

Transplanting human stem cells into the spinal cord of patients with amyotrophic lateral sclerosis (ALS) shows promise.

The amount of cerebral microbleeds can influence the severity of physical and cognitive outcomes in MS patients.

Dimethylfumarate could provide a new treatment option for several neurodegenerative diseases.

Ocrevus treats relapsing and primary progressive multiple sclerosis.

While cancer spending contributes largely to medical spending, it only accounted for 6.3% of growth from 2000 to 2012.

Ocrevus is an investigational, humanized monoclonal antibody that selectively targets CD20-positive B cells in multiple sclerosis.

Findings will allow for improved screenings of drugs that treat MS.

Intensive stem cell transplant cleared all signs of brain inflammation in multiple sclerosis patients.